Market Tracker

05/03 9:13am ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.30
Delayed Data
As of May 02
 0.00 / 0.00%
Today’s Change
0.26
Today|||52-Week Range
0.77
-17.36%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.30
Today’s open0.31
Day’s range0.30 - 0.31
Volume336,780
Average volume (3 months)440,130
Market cap$64.0M
Dividend yield--
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)+27.27%
Earnings growth (this year)-62.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.08-1.16%
VCELVericel Corp+0.13+4.51%
OREXOrexigen Therapeutic...+0.02+4.47%
AKAOAchaogen Inc-0.12-3.54%
Data as of 05/02/2016

Financials

Next reporting dateMay 9, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts